GlassScriptPhysician profile
Melanie W Seybt
NPI 1841310851
$1,666.56
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.83 · 2021: $213 · 2022: $911 · 2023: $345 · 2024: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $633.71 | 2022-2024 | |
| Optinose US, INC. | $335.95 | 2020-2023 | |
| Medtronic, INC. | $284.12 | 2021-2023 | Stealthstation S8 Platform, Nuvent |
| Genzyme Corporation | $102.54 | 2022-2023 | |
| Stryker Corporation | $102.24 | 2022 | |
| Glaxosmithkline, LLC. | $48.91 | 2022-2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $45.87 | 2023 | Dupixent |
| Hikma Pharmaceuticals USA | $34.01 | 2022-2023 | Ryaltris |
| Integra Lifesciences Corporation | $23.14 | 2023 | Codman Isocool Aht, Integra, Microfrance |
| Inspire Medical Systems, INC. | $22.83 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $18.79 | 2022 | |
| Olympus America INC. | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Seybt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.